Obermatt
See Similar Stocks →

Flags

Financial distress

Lifecore Biomedical

NSQ:LFCR · US5147661046
Life Sciences Tools & ServicesSmall

360

12
EV / EBIT4
Price / Owner Earnings65
Owner Earnings Yield1
Dividend Yield1
Price/Sales83
EV / Gross Profit48
Price/Book97
Returns on capital34
EBIT Margin47
Gross Profitability58
Accruals87
Owner Earnings Margin37
Sales growth96
Profit growth30
Reinvestment8
Price momentum28
Debt load9
Refinancing88
Debt Payback1
Liquidity39
Analyst ratings39
Opinion Changes50
Price Target Upside49
Market mood18
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Lifecore Biomedical doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded1986
Employees211
Websitelifecore.com
ISINUS5147661046
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
OphthalmologyOrthopaedicsBiomedical EngineeringBiotechnologyManufacturing

Description

Lifecore Biomedical, Inc. (‘Lifecore’), together with its subsidiaries, a fully integrated contract development and manufacturing organization (‘CDMO’) that offers clinical and commercial capabilities in the development, cGMP manufacturing and asepti…

Analysis

Middle-of-the-road

Lifecore Biomedical, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is fragile. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
17
2023202420252026

All-time high

17

Jun 2026

All-time low

1

Mar 2026

Average rank

8

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
83
31
47
49
Price/Earnings
81
3
1
16
Price/Book
97
29
15
60
Dividend Yield
1
1
1
1
Value (overall)
96
22
8
37

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Lifecore Biomedical with its peers
West Pharmaceutical Services
NYQ:WST
80
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Alpha Teknova
NMQ:TKNO
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Niagen Bioscience
NAQ:NAGE
71
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Fortrea
NSQ:FTRE
42
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Cytek Biosciences
NSQ:CTKB
38
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
AbCellera Biologics
NSQ:ABCL
19
CountryCanada
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →